According to the latest report by IMARC Group, titled “Anti-infectives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the global anti-infectives market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global anti-infectives market size reached US$ 130.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 157.6 Billion on by 2028, exhibiting a growth rate (CAGR) of 3.46% during 2023-2028.
Anti-infectives represent medicines that act against infections, either by killing the infectious agent outright or inhibiting the spread. They consist of antibiotics, antifungals, antivirals, antimalarials, anthelmintics, antiprotozoals, etc. These anti-infectives are generally administered through oral, parenteral, or topical routes. They help to treat minor infectious diseases, including pneumonia and tuberculosis, and give vital immuno-suppressive treatments, such as chemotherapy, to people suffering from cancer. Anti-infectives even prove highly effective during cesarian section, joint replacement, and other routine procedures and surgeries that are associated with a high risk of severe infection. Consequently, they find extensive applications in hospitals, clinics, and other healthcare establishments across the globe.
Request For Sample Report: https://www.imarcgroup.com/anti-infectives-market/requestsample
Industry Trends & Drivers
The elevating incidences of various infectious diseases across countries are primarily driving the anti-infectives market. Additionally, the introduction of novel drugs formulated using several strategies, which include natural products, quorum sensing inhibitors, gallium-based drugs, cyclodextrin inhibitors, biofilm disruptors, light-based antimicrobials, etc., and the increasing innovation in drug discovery processes, including stem cells and organ-on-chip or OOC technologies, to improve drug trial processes are acting as significant growth-inducing factors. Besides this, the rising number of new anti-infective drugs being approved by the regulatory authorities and the growing product adoption, owing to the sudden outbreak of the COVID-19 pandemic and the induced infections, such as aspergillosis, invasive candidiasis, mucormycosis, etc., are also positively influencing the global market. Moreover, the launch of favorable policies by government bodies aimed at supporting the development of new and innovative drugs and the inflating investments in healthcare infrastructure improvements are anticipated to catalyze the anti-infectives market in the coming years.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Type:
- Antibacterial
- Antifungal
- Antiviral
Breakup by Route of Administration:
- Topical
- Oral
- Intravenous (IV)
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Speciality Pharmacies
- Online Stores
- Others
Regional Insights:
- Asia Pacific
- North America
- Europe
- Middle East and Africa
- Latin America
On the geographical front, Asia Pacific enjoys the leading position in the market. This can be attributed to the rising establishment of international companies in the region, on account of low manufacturing costs and cheap labor.
Ask An Analyst: https://www.imarcgroup.com/request?type=report&id=6073&flag=C
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 |
Africa and Europe :- +44-702-409-7331 |
Asia: +91-120-433-0800, +91-120-433-0800